Proscia Launches Concentriq Embeddings and Developer Toolkit to Unleash Pathology AI Development

Proscia: Investment to solidify leadership position in response to rising demand  PHILADELPHIA – June 14, 2022 – Proscia®, a leader in digital and computational pathology solutions, has raised $37 million to advance the way we...

Mindpeak announces scanner agnostic CE-marked PD-L1 AI solution to support Lung Cancer Diagnosis (PresseBox) (Hamburg, 06/09/2022) -- Mindpeak, European leader in Artificial Intelligence in Pathology, today announced the launch of a new CE...

Aiforia Technologies Plc is thrilled to announce it received CE-IVD marking for the Aiforia® Clinical Suite Viewer, a cloud-based platform enabling a holistic approach to cancer diagnostics and prognostics through the viewing of whole slide...

Proscia: Regulatory milestone to accelerate company’s international growth amid expanding presence in Europe PHILADELPHIA–(BUSINESS WIRE)– Proscia, a leader in digital and computational pathology solutions, today...

A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental treatment. In a very small trial done by doctors at New York's Memorial Sloan Kettering...

Gestalt - Hamamatsu unified solution will provide end-to-end support to the entire workflow June 7, 2022 – Spokane, WA. Today, Gestalt Diagnostics, Inc., a leading provider of digital pathology solutions, and Hamamatsu Photonics K.K., a...